The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4
Conditions:   CKD Stage 3b;   CKD Stage 4 Intervention:   Drug: Sevelamer Carbonate Sponsor:   Fan Fan Hou Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2018 Category: Research Source Type: clinical trials

Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
Condition:   Hyperphosphatemia Interventions:   Drug: Placebo;   Drug: Sevelamer Carbonate (GZ419831) Sponsor:   Sanofi Not yet recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2016 Category: Research Source Type: clinical trials

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
Condition:   Hyperphosphatemia Interventions:   Drug: EOS789;   Drug: Placebo;   Drug: Renvela Sponsor:   Chugai Pharmaceutical Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2016 Category: Research Source Type: clinical trials

A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
Condition:   Obesity and GlomerulopathyInterventions:   Drug: High dosage Sevelamer Carbonate + Irbesartan;   Drug: Low dosage Sevelamer Carbonate + Irbesartan;   Drug: IrbesartanSponsor:   Zhi-Hong Liu, M.D.Not yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2015 Category: Research Source Type: clinical trials

An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients
Condition:   Renal Failure ChronicInterventions:   Drug: sevelamer carbonate 800mg;   Drug: sevelamer carbonate 2.4 gSponsor:   Genzyme, a Sanofi CompanyCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2014 Category: Research Source Type: clinical trials

A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722
Condition:   HealthyInterventions:   Drug: AZD1722;   Drug: RenvelaSponsors:   Ardelyx;   AstraZenecaCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2014 Category: Research Source Type: clinical trials